In vivo assessment of catechol O-methyltransferase activity in rabbit skeletal muscle

Autonomic Neuroscience: Basic and Clinical

Volumn 111, Issue 2, 2004, Pages 140-143

  Fujii, Takafumi ^a   Yamazaki, Toji ^a   Akiyama, Tsuyoshi ^a   Sano, Shunji ^b   Mori, Hidezo ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Catechol O methyltransferase; Catecholamine; Entacapone; Microdialysis; Skeletal muscle

Indexed keywords

3,4 DIHYDROXYPHENYLETHYLENE GLYCOL; 4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; ADRENALIN; CATECHOL 2 METHYLTRANSFERASE; CATECHOL 2 METHYLTRANSFERASE INHIBITOR; CATECHOLAMINE; ENTACAPONE; METADRENALIN; METHYLTRANSFERASE; METHYLTRANSFERASE INHIBITOR; NORADRENALIN; NORMETADRENALIN; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CHROMATOGRAPHY; DIALYSATE LEVEL; ELECTROCHEMICAL DETECTION; ENZYME ACTIVITY; INTERSTITIUM; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RABBIT; SKELETAL MUSCLE; TECHNIQUE;

ANIMALS; CATECHOL O-METHYLTRANSFERASE; CATECHOLS; ENZYME INHIBITORS; MALE; METHOXYHYDROXYPHENYLGLYCOL; MICRODIALYSIS; MUSCLE, SKELETAL; RABBITS;

EID: 2942587178     PISSN: 15660702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autneu.2004.02.001     Document Type: Article

References (22)

1. Akiyama T., Yamazaki T. Myocardial interstitial norepinephrine and dihydroxyphenylglycol levels during ischemia and reperfusion. Cardiovasc. Res. 49:2001;78-85
2. Akiyama T., Yamazaki T., Ninomiya I. In vivo monitoring of myocardial interstitial norepinephrine by dialysis techniques. Am. J. Physiol. 261:1991;H1643-H1647
3. Boulton A.A., Eisenhofer G. Catecholamine metabolism: from molecular understanding to clinical diagnosis and treatment. Adv. Pharmacol. 42:1998;273-292
4. Eisenhofer G., Goldstein D.S., Ropchak T.G., Nguyen H.Q., Keiser H.R., Kopin I.J. Source and physiological significance of plasma 3, 4-dihydroxyphenylglycol and 3-methoxy-4-hydroxyphenylglycol. J. Auton. Nerv. Syst. 24:1988;1-14
5. Eisenhofer G., Pecorella W., Pacak K., Hooper D., Kopin I.J., Goldstein D.S. The neuronal and extraneuronal origins of plasma 3-methoxy- 4hydroxyphenylglycol in rats. J. Auton. Nerv. Syst. 50:1994;93-107
6. Goldstein D.S., Eisenhofer G., Stull R., Folio C.J., Keiser H.R., Kopin I.J. Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans. J. Clin. Invest. 81:1998;213-220
7. Illi A., Sundberg S., Ojala-Karlsson P., Korhonen P., Scheinin M., Gordin A. The effect of entacapone on the disposition and hemodynamic effects of intravenous isoproterenol and epinephrine. Clin. Pharmacol. Ther. 58:1995;221-227
8. Karhunen T., Tilgmann C., Ulmanen I., Julkunen I., Panula P. Distribution of catechol-O-methyltransferase enzyme in rat tissues. J. Histochem. Cytochem. 42:1994;1079-1090
9. Lambert G.W., Kaye D.M., Vaz M., Cox H.S., Turner A.G., Jennings G.L., Esler M.D. Regional origins of 3-methoxy-4-hydroxyphenylglycol in plasma: effects of chronic sympathetic nervous activation and denervation, and acute reflex sympathetic stimulation. J. Auton. Nerv. Syst. 55:1995;169-178
10. 3H-DL-norepinephrine by intact rabbit aorta and by isolated adventitia and media. J. Pharmacol. Exp. Ther. 190:1974;210-226
11. Lindmar R., Löffelholz K. Neuronal and extraneuronal uptake and efflux of catecholamines in the isolated heart. Naunyn-Schmiedeberg's Arch. Pharmacol. 284:1974;63-92
12. Lundvall J., Edfeldt H. Very large range of baroreflex sympathetic control of vascular resistance in human skeletal muscle and skin. J. Appl. Physiol. 76:1994;204-211
13. Männistö P.T., Kaakkola S. Catechol-O-metyltransferase (COMT) activity: biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol. Rev. 51:1999;593-628
14. Scheinin M., Illi A., Koulu M., Ojara-Karsson P. Norepinephrine metabolites in plasma as indicators of pharmacological inhibition of monoamine oxidase and catechol O-methyltransferase. Adv. Pharmacol. 42:1998;367-370
15. Spraul M., Anderson E.A., Bogardus C., Ravussin E. Muscle sympathetic nerve activity in response to glucose ingestion. Impact of plasma insulin and body fat. Diabetes. 43:1994;191-196
16. Takauchi Y., Kitagawa H., Kawada T., Akiyama T., Yamazaki T. High-performance liquid chromatographic determination of myocardial interstitial dihydroxyphenylglycol. J. Chromatogr., B, Biomed. Sci. Appl. 693:1997;218-221
17. Tokunaga N., Yamazaki T., Akiyama T., Sano S., Mori H. In vivo monitoring of norepinephrine and its metabolites in skeletal muscle. Neurochem. Int. 43:2003;573-580
18. Tokunaga N., Yamazaki T., Akiyama T., Mori H. Detection of 3-methoxy-4-hydroxyphenylglycol in rabbit skeletal muscle microdialysate. J. Chromatogr., B, Biomed. Sci. Appl. 798:2003;163-166
19. Toumainen P., Reenila I., Männistö P.T. Validation of assay of catechol-O-methyltransferase activity in human erythrocytes. J. Pharm. Biomed. Anal. 14:1996;515-523
20. Trendelenburg U. The extraneuronal uptake and metablosim of catecholamines in the heart. Paton D.M. The Mechanism of Neuronal and Extranneuronal Transport of Catecholamines. 1978;259-280 Raven Press, New York
21. Tsunoda M., Takezawa K., Masuda M., Imai K. Rat liver and kidney catechol-O-methyltransferase activity measured by high-performance liquid chromatography with fluorescence detection. Biomed. Chromatogr. 16:2002;536-541
22. Yamazaki T., Akiyama T., Shindo T. Routine high-performance liquid chromatographic determination of myocardial interstitial norepinephrine. J. chromatogr., B, Biomed. Sci. Appl. 670:1995;328-331